Skip to content
  • About
    • About
    • Capabilities & Team
    • Summary of Curriculum Vitae for Richard E. Ward, MD, MBA
    • Curriculum Vitae of Richard E. Ward, MD, MBA
    • Clients
    • Products
  • Approach
    • Approach
    • People
    • Process
    • Technology
    • Culture
    • Economics
    • Leadership
    • Bibliography
  • Contact
  • Blog
  • About
    • About
    • Capabilities & Team
    • Summary of Curriculum Vitae for Richard E. Ward, MD, MBA
    • Curriculum Vitae of Richard E. Ward, MD, MBA
    • Clients
    • Products
  • Approach
    • Approach
    • People
    • Process
    • Technology
    • Culture
    • Economics
    • Leadership
    • Bibliography
  • Contact
  • Blog
Clinical Practice Guidelines and Protocols

In response to a JAMA Viewpoint offering 4 principles for public health post COVID, I say yes, but we need a 5th principle – Science staying in its lane.

In a recent issue of JAMA, Daniel Morgan (U Maryland) and Deborah Korenstein (Icahn/Mt. Sinai) offered a viewpoint article that revisits the important evaluative conversation

Read More »
Dr. Ward December 7, 2025 No Comments
Clinical Practice Guidelines and Protocols

Time for a temporarily privatized CDC policymaking process, sponsored and funded by provider & payer organizations, professional societies and states.

Recent efforts by HHS Secretary Kennedy to politicize CDC policymaking leave us without the science-driven process the nation requires. Therefore, while we wait impatiently for

Read More »
Dr. Ward September 2, 2025 9 Comments
Clinical Practice Guidelines and Protocols

Trump/Musk killed AHRQ, but in a sense, the death has been playing out over 25 years. Recalling 4 eras of the agency and my dream for its eventual rebirth.

Slashing and Dissolving As reported by the Kaiser Family Foundation’s Health News site blog, last week the Trump administration “dissolved” the Agency for Healthcare Research

Read More »
Dr. Ward April 8, 2025 No Comments
Clinical Practice Guidelines and Protocols

In the debate about price vs utilization as the main driver of geographic variation in cost of care, I say don’t get distracted from innovation.

I want to call your attention to a very thoughtful blog published by the semi-retired health care journalist, Merrill Goozner: the GoozNews Substack. Goozner’s most

Read More »
Dr. Ward February 21, 2025 No Comments
ACO Reimbursement and Gain Sharing

CMS Innovation Center engages in linguistic manipulation and health economics denialism in new definition of “VBC”

There are many good people at the CMS Innovation Center (CMMI). They mean well. They are our friends. But friends need to call out friends

Read More »
Dr. Ward January 30, 2024 4 Comments
Healthgrades page shown on iPad
Continuous Quality Improvement (CQI)

What should we do when there is a clash between two noble goals: consumer transparency and quality improvement? Five proposed principles.

For many years, I’ve been following and writing blog posts about one of my heroes, Don Berwick, a physician leader, Obama-era CMS Administrator and one

Read More »
Dr. Ward December 14, 2021 6 Comments
Accountable Care Organizations (ACOs)

Berwick and Gilfillan offer six recommendations for reinventing CMMI. My response is yes, but they don’t address the #1 issue: failure to achieve critical mass.

In a recent health policy viewpoint article in JAMA, Drs. Don Berwick and Rick Gilfillan noted that, although the CMS Center for Medicare and Medicaid

Read More »
Dr. Ward April 7, 2021 3 Comments
Clinical Practice Guidelines and Protocols

Defensible COVID-19 vaccine prioritization policy will require bravery and explicit principles and analytics. We offer example principles and propose a 6-step process.

For almost a year, the weary public has been receiving a confusing mix of information and misinformation and witnessing an inconsistent and sometimes incoherent policy-making

Read More »
Dr. Ward December 7, 2020 1 Comment
ACO Strategy

3 steps for executing an effective consumer-driven physician strategy

To meet post-pandemic expectations of consumers, healthcare providers need a strategy for consumer-focused care processes, supported by consumer-friendly provider networks and enabling technology.

Read More »
Dr. Ward December 1, 2020 No Comments
Clinical Practice Guidelines and Protocols

Henry Ford observational study that shows 66% in-hospital mortality reduction from hydroxychloroquine seems to be guilty of “heroic propensity score” problem

During the 1990s, I served as the director of the Center for Clinical Effectiveness at the Henry Ford Health System in Detroit.  I was lucky

Read More »
Dr. Ward August 7, 2020 No Comments
« Previous Page1 Page2 Page3 Page4 Next »
Copyright 2026 Reward Health Sciences, Inc.
Linkedin